首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Systemic responses after bronchial aspirin challenge in sensitive patients with asthma.
【24h】

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma.

机译:敏感哮喘患者支气管阿司匹林激发后的全身反应。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In aspirin-sensitive patients with asthma, bronchial obstruction induced by oral aspirin may be associated with extrabronchial symptoms, suggesting the systemic character of the response. OBJECTIVE: Go assess potential systemic effects of local aspirin challenge, hemopoietic progenitors were measured in the peripheral blood of challenged patients. METHODS: In 19 patients with a history of aspirin-induced asthma, placebo-controlled bronchial challenges with lysine-aspirin were performed. Peripheral blood was collected before and then 1 hour and 20 hours after challenge (placebo or aspirin). Using the flow-cytometric method, the numbers of leukocyte (CD34+ cells) and eosinophil (CD34+CD125+ cells) progenitors were determined. RESULTS: The challenge was positive in 13 patients; 6 patients had isolated local bronchial reaction, and 7 patients developed systemic symptoms (bronchial and extrabronchial). In patients with positive challenge (n = 13), leukocyte progenitors increased significantly at1 hour and 20 hours after challenge (mean, 0.04% at baseline, 0.066% at 1 hour after challenge, and 0.073% at 20 hours; P < .05). Eosinophil progenitors raised significantly from mean 0.017% before challenge to 0.04% (P < .05) at 20 hours after the challenge. At 20 hours after the challenge, the increase in leukocyte and eosinophil progenitors was observed only in patients with systemic reactions. Positive aspirin challenge was associated with a significant increase in eotaxin 2 serum concentration. CONCLUSION: This study demonstrated that bronchial challenge with aspirin may involve systemic reactions and is associated with mobilization of leukocyte and eosinophil progenitor cells from the bone marrow.
机译:背景:在对阿司匹林敏感的哮喘患者中,口服阿司匹林引起的支气管阻塞可能与支气管外症状有关,提示该反应的系统性。目的:评估局部阿司匹林激发的潜在全身作用,在激发患者的外周血中测定造血祖细胞。方法:在19名有阿司匹林诱发哮喘病史的患者中,进行了由赖氨酸阿司匹林进行的安慰剂对照支气管激发试验。在激发之前(安慰剂或阿司匹林),然后在激发后1小时和20小时收集外周血。使用流式细胞仪方法,确定白细胞(CD34 +细胞)和嗜酸性粒细胞(CD34 + CD125 +细胞)祖细胞的数量。结果:13名患者的挑战为阳性。 6例患者出现局部支气管反应,7例出现全身症状(支气管和支气管外)。攻击阳性的患者(n = 13),在攻击后1小时和20小时白细胞祖细胞显着增加(平均值,基线时为0.04%,攻击后1小时为0.066%,20小时时为0.073%; P <.05) 。嗜酸性粒细胞祖细胞从攻击前的平均0.017%显着升高到攻击后20小时的0.04%(P <.05)。攻击后20小时,仅在全身反应患者中观察到白细胞和嗜酸性粒细胞祖细胞增加。积极的阿司匹林攻击与嗜酸性粒细胞趋化因子2血清浓度的显着增加有关。结论:这项研究表明,阿司匹林对支气管的攻击可能涉及全身反应,并与骨髓中白细胞和嗜酸性粒细胞祖细胞的动员有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号